• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Ivuxolimab Antibody – Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5819942

Ivuxolimab, an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody, targets a costimulatory receptor found on activated CD4+ and CD8+ T cells. It demonstrates antitumor properties and may exhibit immunostimulatory activity. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Ivuxolimab, Monoclonal Antibody
Full Product Name
Ivuxolimab
Clonality
Monoclonal
Species Reactivity
CD4+ and CD8+ T cells
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
2128729-41-7

Other Notes

Small volumes of anti-Ivuxolimab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Ivuxolimab purchase

MBS5819942 is an antibody targeting Ivuxolimab. Reactive in CD4+ and CD8+ T cells.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000